Published: 15 January 2026

About Medsafe

Consultations – Archive

This section contains links to outcomes of previous consultations.

Date	Consultation
16 February 2023	Proposed warning and advisory statements for ocular decongestants for eye redness and/or minor eye irritation
13 July 2022	Proposed warning and advisory statements relating to the harm of opioid abuse
27 June 2022	Proposed warning and advisory statements relating to the harm of long-term use and overuse of stimulant laxatives
13 May 2022	Review of fees payable under the Medicines Act 1981 (PDF 456 KB, 24 pages)
12 April 2021	Plan to update the New Zealand Code of Good Manufacturing Practice from the PIC/S Guide PE009-8 to PE009-14 version
29 March 2021	Proposed changes to paracetamol warning and advisory statements
14 September 2020	Proposed warning statements for substances (eg, allergens) in medicines that may cause undesirable reactions
1 July 2020	Survey of consumers on ADR reporting: Outcome report - July 2020 (PDF 412 KB, 23 pages)
1 October 2019	Changes to the prescribing restrictions of riluzole
27 June 2019	Revision of CMN Form B
18 March 2019	Proposed warning statement regarding a fire hazard on the labels of paraffin-based skin products
1 March 2019	Survey of health care professionals on ADR reporting: Outcome report - March 2019 (PDF 463 KB, 34 pages)
1 December 2018	Updating the guidance document 'How to change the legal classification of a medicine in New Zealand'
8 November 2018	Update to the Guideline on the Regulation of Therapeutic Products – Part 11: Clinical Trials
25 May 2018	Fees Payable under the Medicines Regulations 1982: Outcome of Consultation
27 October 2017	Changes to the Label Statements Database for sedating antihistamines available without prescription
26 September 2017	Change to warning statements on labels of oral non-steroidal anti-inflammatory drugs (NSAIDs) available without a prescription
1 June 2017	Addition of warning statements on labels of topical miconazole containing medicines available without prescription
12 May 2017	Proposal to change to warning statements on labels of OTC loratadine and desloratadine medicines
11 November 2016	Proposed changes to the data sheet format
2 September 2015	Proposed New Zealand Medicines and Medical Devices Recall Code
31 August 2015	Proposed Guideline on the Regulation of Therapeutic Products in New Zealand. Part 8: Pharmacovigilance
19 August 2015	Proposed addition of warning statements on labels of OTC oral and topical diclofenac medicines
28 May 2015	Proposed Amendments to Regulations under the Medicines Act 1981 - Report of analysis of submission and final decisions
13 March 2015	Proposed amendment to the Medicine Regulations 1984 re fluoride in drinking water
7 August 2014	Response to requests for increased transparency regarding MAAC processes
9 July 2014	Medsafe's proposed changes to evaluation administrative processes
23 June 2014	Planned changes to the Label Statements Database for codeine-containing medicines - REVISED
21 May 2014	Proposed revision of the abbreviated process policy
2 May 2014	Planned changes to the prescribing restrictions for clozapine
27 March 2014	Proposed planned changes to the Label Statements Database for aspirin
27 March 2014	Planned removal of warning statements from the Label Statements Database for loratadine and cetirizine
5 February 2014	Medsafe's consultation with the therapeutic products industry on improving communication
8 January 2014	Standards for Contraceptive Devices supplied in New Zealand - Summary of Consultation
1 July 2013	Planned changes to packaging requirements for antidepressants
22 May 2013	Trans-Tasman Early Warning System of safety concerns with medicines and medical devices
24 April 2013	Proposed changes to GMP evidence required for active pharmaceutical ingredients
15 March 2013	Over-the-counter (OTC) medicines business process reforms
30 September 2012	Proposed Business Rule for Publication of Datasheets
21 October 2010	Revision of the New Zealand Good Clinical Research Practice Guideline
7 May 2010	Proposal to Widen Prescriber Access to Clozapine
11 December 2009	Submission and Publication Processes for Data Sheets and Consumer Medicine Information (CMI) on the Medsafe Website
19 June 2009	Proposed changes to fees payable Under the Medicines Regulations 1984
19 June 2009	Changes to Medsafe's Administrative Processes and Fees Effective 1 July 2009
21 April 2009	Review of the abbreviated evaluation process (Word 39 KB, 5 pages)
4 March 2009	Draft Guideline for the Transfer of Analytical Procedures